Document:

19th Supplemental Indenture

 Exhibit 4.2 

 
  

 
 NINETEENTH SUPPLEMENTAL
INDENTURE 
 by and among 
 STANDARD PACIFIC CORP. AND THE GUARANTORS PARTY HERETO 
 and

 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., 

as Trustee 
  

 
 Dated as of
August 6, 2012 
  
  

(Supplemental to the Indenture dated as of April 1, 1999) 

 
  

 

 NINETEENTH SUPPLEMENTAL INDENTURE 

This Nineteenth Supplemental Indenture, dated as of August 6, 2012 (the “Nineteenth Supplemental Indenture”), is entered
into among Standard Pacific Corp., a Delaware corporation (the “Company”), the guarantors listed on the signature page hereto (the “Guarantors”), and The Bank of New York Mellon Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association, Bank One Trust Company, N.A. and First National Bank of Chicago), as trustee (the “Trustee”). 
 W I T N E S S E T H: 
 WHEREAS, this Nineteenth Supplemental Indenture is
supplemental to the Indenture, dated as of April 1, 1999 (the “Original Indenture”), as previously supplemented by that certain First Supplemental Indenture dated as of April 13, 1999, Second Supplemental Indenture dated as of
September 5, 2000, Third Supplemental Indenture dated as of December 28, 2001, Fourth Supplemental Indenture dated as of March 4, 2003, Fifth Supplemental Indenture dated as of May 12, 2003, Sixth Supplemental Indenture dated as
of September 23, 2003, Seventh Supplemental Indenture dated as of March 11, 2004, Eighth Supplemental Indenture dated as of March 11, 2004 (the “Eighth Supplemental Indenture”), Ninth, Supplemental Indenture dated as of
August 1, 2005, Tenth Supplemental Indenture dated as of August 1, 2005 (the “Tenth Supplemental Indenture”), the Eleventh Supplemental Indenture dated as of February 22, 2006 , the Twelfth Supplemental Indenture dated as of
May 5, 2006, the Thirteenth Supplemental Indenture dated as of October 8, 2009, the Fourteenth Supplemental Indenture dated as of May 3, 2010 (the “Fourteenth Supplemental Indenture”), Fifteenth Supplemental Indenture dated
as of December 22, 2010 (the “Fifteenth Supplemental Indenture”), Sixteenth Supplemental Indenture dated as of December 22, 2010 (the “Sixteenth Supplemental Indenture”), Seventeenth Supplemental Indenture dated as of
December 22, 2010 and Eighteenth Supplemental Indenture dated as of the date hereof (the “Eighteenth Supplemental Indenture”) (the Original Indenture, as supplemented, the “Indenture”); 

WHEREAS, the following notes have been previously issued by the Company and remain outstanding under the Indenture: 1 1/4% Convertible
Notes due 2032 in the aggregate amount of $220,000,000 issued pursuant to the Eighteenth Supplemental Indenture; 8 3/8% Senior Notes due 2021 in the aggregate amount of $400,000,000 issued pursuant to the Sixteenth Supplemental Indenture; 8 3/8%
Senior Notes due 2018 in the aggregate amount of $575,000,000 issued pursuant to the Fourteenth Supplemental Indenture and Fifteenth Supplemental Indenture; 7% Senior Notes due 2015 in the aggregate amount of $29,789,000 issued pursuant to the Tenth
Supplemental Indenture; and 6 1/4% Senior Notes due 2014 issued in the aggregate amount of $4,971,000 pursuant to the Eighth Supplemental Indenture (collectively, the “Notes”); 

WHEREAS, the Trustee, the Company and the Guarantors desire to amend the Indenture to modify certain provisions of the Indenture;

 WHEREAS, pursuant to Section 9.01 of the Original Indenture, the Company and the Trustee may execute a supplemental
indenture without the consent of the holders of the 

  
 2 

 
Outstanding Notes to make any change that does not adversely affect the rights of the holders; and 
 WHEREAS, all things necessary to make this Nineteenth Supplemental Indenture a valid agreement of the Company, the Guarantors and the Trustee, in accordance with its terms, and a valid amendment of, and
supplement to, the Indenture have been done. 
 NOW, THEREFORE, the parties hereto agree, as follows: 

ARTICLE ONE 

AMENDMENTS TO INDENTURE 
 Section 1.01. Amendments. The terms of the Indenture and any corresponding provisions in the Notes are hereby amended, supplemented, modified or deleted as follows: 

(a) The definition of “Trust Officer” set forth in Section 1.01 of the Indenture is hereby amended and restated as
follows: 
 ““Trust Officer” means, with respect to the Trustee, any officer
assigned to the Corporate Trust Administration - Corporate Finance Unit (or any successor division or unit) of the Trustee located at the Corporate Trust Office of the Trustee, who shall have direct responsibility for the administration of this
Indenture, and for the purposes of Section 7.01(c)(2) shall also include any other officer of the Trustee to whom any corporate trust matter is referred because of such officer’s knowledge of and familiarity with the particular
subject.” 
 (b) The following definition is hereby added to Section 1.01 of the Indenture in its proper location:

 ““Corporate Trust Office of the Trustee” means the office of the Trustee at which
at any particular time its corporate trust business in Chicago, Illinois shall be principally administered, which office as of the date of this instrument is located at the address of the Trustee specified in Section 10.02 hereof or such other
address as to which the Trustee gives notice to the Company, except that with respect to presentation of Notes for payment or for registration of transfer or exchange, such term shall mean the office or agency of the Trustee, which office at the
date of this instrument is located at 111 Sanders Creek Parkway, East Syracuse, NY 13057; Attention: Global Corporate Trust, or, in the case of any of such offices or agency, such other address as the Trustee may designate from time to time by
notice to the Company.” 
 (c) The text of clause (g) in Section 7.02 of the Indenture is hereby amended and
restated as follows: 
 “For all purposes under this Indenture, the Trustee shall not be deemed to have
notice or knowledge of any Event of Default (other than under Section 6.01(1) or 6.01(2)) unless a Trust Officer assigned to and working in the Trustee’s corporate 

  
 3 

 
trust office has actual knowledge thereof or unless written notice of any Event of Default is received by a Trust Officer of the Trustee at its address specified in Section 10.02 hereof and
such notice references the Securities generally, the Company or this Indenture. ” 
 (d) The following Sections 7.02(h) and
7.02(i) of the Indenture are hereby added immediately following Section 7.02(g) of the Indenture: 

“(h) Anything in this Indenture notwithstanding, in no event shall the Trustee be liable to the Company for special,
indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), even if the Trustee has been advised as to the likelihood of such loss or damage and regardless of the form of action.

 (i) The Trustee shall not be responsible or liable to the Company for any failure or delay in the performance
of its obligations under this Indenture arising out of or caused, directly or indirectly, by circumstances beyond its control, including, without limitation, acts of God; earthquakes; fire; flood; terrorism; wars and other military disturbances;
sabotage; epidemics; riots; interruptions; loss or malfunctions of utilities, computer (hardware or software) or communication services; accidents; labor disputes; acts of civil or military authority and governmental action.” 

(e) In the sixth sentence of Section 7.07 of the Indenture, the term “bad faith” is hereby replaced with “willful
misconduct.” 
 (f) The notice address of the Company contained in Section 10.02 of the Indenture is hereby amended
and restated to read as follows: 
 “Standard Pacific Corp. 

15360 Barranca Parkway 
 Irvine, California 92618 
 Attn: Secretary” 

(g) The notice address of the Trustee contained in Section 10.02 of the Indenture is hereby amended and restated to read as follows:

 “The Bank of New York Mellon Trust Company, N.A. 
 2 North LaSalle, Suite 1020 
 Chicago, IL 60602 

Facsimile: (312) 827-8542 
 Attn: Corporate Trust Administration” 
 (h) The following is hereby added as
a new paragraph at end of Section 10.02 of the Indenture: 

  
 4 

 “The Trustee agrees to accept and act upon instructions or directions
from the Company pursuant to this Indenture sent by unsecured e-mail, pdf, facsimile transmission or other similar unsecured electronic methods, provided, however, that the Trustee shall have received an incumbency certificate listing persons
designated to give such instructions or directions and containing specimen signatures of such designated persons, which such incumbency certificate shall be amended and replaced whenever a person is to be added or deleted from the listing. If the
Company elects to give the Trustee e-mail or facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions shall
be deemed controlling. The Trustee shall not be liable to the Company for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions
conflict or are inconsistent with a subsequent written instruction. The Company agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without limitation the risk
of the Trustee acting on unauthorized instructions, and the risk or interception and misuse by third parties.” 
 (i) The
following two paragraphs are hereby added as new paragraphs at end of Section 10.08 of the Indenture: 

“EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OF ANY SERIES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. 

THE COMPANY IRREVOCABLY CONSENTS AND SUBMITS, FOR ITSELF AND IN RESPECT OF ANY OF ITS ASSETS OR PROPERTY, TO THE
NONEXCLUSIVE JURISDICTION OF ANY COURT OF THE STATE OF NEW YORK OR ANY UNITED STATES FEDERAL COURT SITTING, IN EACH CASE, IN THE BOROUGH OF MANHATTAN, THE CITY OF NEW YORK, NEW YORK, UNITED STATES OF AMERICA, AND ANY APPELLATE COURT FROM ANY THEREOF
IN ANY SUIT, ACTION OR PROCEEDING THAT MAY BE BROUGHT IN CONNECTION WITH THIS INDENTURE OR THE SECURITIES, AND WAIVES ANY IMMUNITY FROM THE JURISDICTION OF SUCH COURTS. THE COMPANY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY
OBJECTION TO ANY SUCH SUIT, ACTION OR PROCEEDING THAT MAY BE BROUGHT IN SUCH COURTS WHETHER ON THE GROUNDS OF VENUE, RESIDENCE OR DOMICILE OR ON THE GROUND THAT ANY SUCH SUIT, ACTION OR PROCEEDING HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. THE
COMPANY AGREES, TO THE FULLEST EXTENT THAT IT LAWFULLY MAY DO SO, THAT FINAL JUDGMENT IN ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A 

  
 5 

 
COURT SHALL BE CONCLUSIVE AND BINDING UPON THE COMPANY, AND WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION TO THE ENFORCEMENT BY ANY COMPETENT COURT IN THE COMPANY’S
JURISDICTION OF ORGANIZATION OF JUDGMENTS VALIDLY OBTAINED IN ANY SUCH COURT IN NEW YORK ON THE BASIS OF SUCH SUIT, ACTION OR PROCEEDING; PROVIDED, HOWEVER, THAT THE COMPANY DOES NOT WAIVE, AND THE FOREGOING PROVISIONS OF THIS SENTENCE SHALL NOT
CONSTITUTE OR BE DEEMED TO CONSTITUTE A WAIVER OF, (I) ANY RIGHT TO APPEAL ANY SUCH JUDGMENT, TO SEEK ANY STAY OR OTHERWISE TO SEEK RECONSIDERATION OR REVIEW OF ANY SUCH JUDGMENT OR (II) ANY STAY OF EXECUTION OR LEVY PENDING AN APPEAL FROM, OR
A SUIT, ACTION OR PROCEEDING FOR RECONSIDERATION OF, ANY SUCH JUDGMENT.” 
 ARTICLE TWO 

MISCELLANEOUS 
 Section 2.01 Governing Law. The laws of the State of New York shall govern this Nineteenth Supplemental Indenture. 
 Section 2.02. No Adverse Interpretation of Other Agreements. This Nineteenth Supplemental Indenture may not be used to interpret another indenture, loan or debt agreement of the Company or a
Subsidiary. Any such indenture, loan or debt agreement may not be used to interpret this Nineteenth Supplemental Indenture. 

Section 2.03. No Recourse Against Others. A director, officer, employee, controlling person, manager or equity holder, as
such, of the Company shall not have any liability for any obligations of the Company under this Nineteenth Supplemental Indenture or for any claim based on, in respect of or by reason of, such obligations or their creation. 

Section 2.04. Successors and Assigns. All covenants and agreements of the Company in this Nineteenth Supplemental Indenture
shall bind its successors and assigns. All agreements of the Trustee in this Nineteenth Supplemental Indenture shall bind its successors and assigns. 
 Section 2.05 Duplicate Originals. The parties may sign any number of copies of this Nineteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent
the same agreement. 
 Section 2.06 Severability. In case any one or more of the provisions contained in this
Nineteenth Supplemental Indenture shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Nineteenth Supplemental Indenture.

  
 6 

 Section 2.07. Amendment and Modification. This Nineteenth Supplemental Indenture
may be amended, modified, or supplemented only by written agreement of each of the parties hereto. 
 Section 2.08.
Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Nineteenth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are
made solely by the Company, and the Trustee assumes no responsibility for their correctness. 

  
 7 

 IN WITNESS WHEREOF, the parties hereto have executed this Nineteenth Supplemental Indenture
by their officers thereunto as of this 6th day of August, 2012. 
  

					
	STANDARD PACIFIC CORP.
		
	By:	 	 /s/ Scott Dawson Stowell

		 	Name:	 	Scott Dawson Stowell
		 	Title:	 	Chief Executive Officer
	
	LAGOON VALLEY RESIDENTIAL, LLC
		 	By:	 	Standard Pacific Corp., its Sole Member
	
	 STANDARD PACIFIC OF TONNER
 HILLS, LLC

		 	By:	 	 Standard Pacific Corp., its Sole

Member

			
		 	By:	 	 /s/ Scott Dawson Stowell

		 	Name:	 	Scott Dawson Stowell
		 	Title:	 	Chief Executive Officer
	
	HSP ARIZONA, INC.
	
	HWB INVESTMENTS, INC.
	
	STANDARD PACIFIC 1, INC.
	
	STANDARD PACIFIC OF ARIZONA, INC.
	
	STANDARD PACIFIC OF COLORADO, INC.
	
	 STANDARD PACIFIC OF FLORIDA
 GP, INC.

	
	STANDARD PACIFIC OF LAS VEGAS, INC.
	
	 STANDARD PACIFIC OF ORANGE
 COUNTY, INC.

	
	 STANDARD PACIFIC OF SOUTH FLORIDA
 GP, INC.

 
					
	STANDARD PACIFIC OF SOUTH FLORIDA
			
		 	By:	 	Standard Pacific of South Florida GP, Inc., its Managing Partner
	
	STANDARD PACIFIC OF TAMPA GP, INC.
	
	STANDARD PACIFIC OF TAMPA
	By:	 	Standard Pacific of Tampa GP, Inc.,
		 	its Managing Partner
	
	STANDARD PACIFIC OF TEXAS, INC.
	
	 STANDARD PACIFIC OF THE CAROLINAS,
 LLC

	
	 STANDARD PACIFIC OF WALNUT HILLS,
 INC.

	
	WESTFIELD HOMES USA, INC.
		
	By:	 	 /s/ Scott Dawson Stowell

		 	Name:	 	Scott Dawson Stowell
		 	Title:	 	Chief Executive Officer

 
			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,
	as Trustee
		
	By:	 	 /s/ Melonee Young

		 	Name: Melonee Young
		 	Title:   Vice PresidentEX-10.1

 Exhibit 10.1 
 August 11, 2011 
 RELEASE AND SEVERANCE COMPENSATION AGREEMENT

 THIS RELEASE AND SEVERANCE COMPENSATION AGREEMENT (the “Agreement”) is made and entered into effective
September 1. 2011, (the “Effective Date”) between and among Ross E. Taubman, DPM an individual (the “Executive”) and ProAssurance Group Services Corporation, an Alabama corporation (“PRA Group Services”), on its
own behalf and on behalf of Podiatry Insurance Company of America (“PICA”) and ProAssurance Corporation (“ProAssurance”). ProAssurance Group Services Corporation, Podiatry Insurance Company of America, and ProAssurance
Corporation are hereinafter collectively referred to as the “Companies.” 
 RECITALS: 

The Executive, as of the Effective Date, has agreed to leave private practice and become an executive officer of PICA in which capacity he will provide
provides services to the Companies as an at will employee.. Executive will be employed at PICA’s offices located at 3000 Meridian Boulevard, Suite 400, Franklin, Tennessee 37067 in Williamson County, Tennessee, which will be Executive’s
primary location of employment on date of this Agreement. The Companies have offered to expand protection to the Executive in the form of severance benefits payable on termination of employment under certain circumstances in consideration of
Executive’s agreement to become an employee of PRA Group Services. PRA Group Services and Executive have entered into this Agreement to evidence the terms and conditions for payment of severance benefits upon termination of Executive’s
employment as described herein. 
 AGREEMENT 

NOW, THEREFORE, These Premises considered, and in consideration of the mutual covenants and promises in this Agreement, the
sufficiency of which is hereby acknowledged, the parties agree as follows: 
 1. Definitions. For purposes of this
Agreement, the following terms shall have the meanings set forth below: 
 (a) “Annual Base Salary” of the Executive
shall be defined as the Executive’s annual base rate of compensation in effect as of the Date of Termination (herein defined), but in no event less than the greater of: (A) the Executive’s initial annual base rate of $350,000; or
(B) the Executive’s annual base rate of compensation in effect as of the end of the last calendar quarter preceding the Date of Termination. 
 (b) “Average Annual Incentive Award(s) and Bonus(es)” of the Executive shall be defined as the amount equal to the average of the annual incentive award(s) and bonus(es) paid to Executive in
each of the three complete calendar years prior to the Date of Termination or, if shorter, in each of the complete calendar years during the Executive’s entire period of employment with the Companies. The Annual Incentive Award(s) and Bonus(es)
shall mean the dollar value of the cash or other consideration paid to the Executive by the Companies 

 
as annual performance based compensation (whether or not deferred) in each calendar year during said period; the performance based compensation shall be deemed to be paid to Executive in the
calendar year that the Executive is notified of the amount of the award of the performance based compensation and has the right to accept payment of the award. The Executive’s annual incentive awards and bonuses do not include long-term
incentive compensation; therefore, Annual Incentive Awards and Bonuses shall be calculated excluding the value of options to purchase stock, performance shares, restricted stock units, or other long-term incentives; 

(c) “Beneficial Ownership” is used as such term is used within the meaning of Rule 13d-3 promulgated under the Exchange Act.

 (d) “Board” means the Board of Directors of ProAssurance either acting as a full Board or through its Compensation
Committee. 
 (e) “Cause” means: (i) the Executive has been convicted in a federal or state court of a crime
classified as a felony; (ii) action or inaction by the Executive (A) that constitutes embezzlement, theft, misappropriation or conversion of assets of the Companies which alone or together with related actions or inactions involve assets
of more than a de minimus amount or that constitutes intentional fraud, gross malfeasance of duty, or conduct grossly inappropriate to Executive’s office, and (B) such action or inaction has adversely affected or is likely to
adversely affect the business of the Companies, taken as a whole, or has resulted or is intended to result in a direct or indirect gain or personal enrichment of Executive to the detriment of the Companies; or (iii) Executive has been grossly
inattentive to, or in a grossly negligent manner failed to competently perform, Executive’s job duties and the failure was not cured within 45 days after written notice from ProAssurance. 

(f) “Code” means the Internal Revenue Code of 1986, as amended 

(g) “Change of Control” shall mean the occurrence of any one of the following events during the term of this Agreement:

 (i) an acquisition of the voting securities of ProAssurance by any Person, immediately after which such Person has
Beneficial Ownership of more than 50.1% of the combined voting power of ProAssurance’s then outstanding voting securities, or an acquisition of the voting securities of PICA by any Person, other than a direct or indirect subsidiary of
ProAssurance, immediately after which such Person has Beneficial Ownership of more than 50.1% of the combined voting power of PICA’s then outstanding voting securities; 
 (ii) a merger, consolidation or reorganization involving ProAssurance or PICA in which an entity other than ProAssurance or PICA (as applicable) is the surviving entity or in which ProAssurance or PICA
(as applicable) is the surviving entity and any one Person, or more than one Person acting as a group (as defined in Section 409A of the Code), acquires ownership of stock of ProAssurance or PICA (as applicable) that together with the stock
held by such Person or group, constitutes more than 50.1% of the outstanding voting securities of the surviving entity; or 

(iii) the sale or other disposition of substantially all of the assets of ProAssurance or PICA (as defined in the regulations under
Section 409A of the Code); or 

  
 2 

 (iv) any other transaction that results in ProAssurance no longer having direct or indirect
control of a majority of the outstanding voting securities of PICA or the successor to its business, so long as any one Person, or more than one Person acting as a group (as defined in Section 409A of the Code), acquires ownership of stock of
PICA or the successor to its business that, together with the stock held by such Person or group, constitutes more than 50.1% of the outstanding voting securities of the surviving entity. 

In no event shall a Change of Control be deemed to have occurred, with respect to Executive, if the Executive is part of a purchasing
group which consummates a Change of Control Transaction. The Executive shall be deemed “part of a purchasing group” for purposes of the preceding sentence if the Executive is an equity participant or has agreed to become an equity
participant in the purchasing company or group (except for ownership of less than 5% of the stock of the purchasing company). 

(h) “Change of Control Transaction” means any of the transactions as described in subparagraphs (i), (ii) and
(iii) of Section 1(g) hereof. 
 (i) “Disability” means a serious injury or illness that requires Executive
to be under regular care of a licensed medical physician and renders the Executive incapable of performing the essential functions of the Executive’s position for twelve (12) consecutive months as determined by the Board in good faith and
upon receipt of and in reliance on competent medical advice from one or more individuals selected by the Board, who are qualified to give professional medical advice. Executive will submit to such medical or psychiatric examinations and tests as
such medical professional deems necessary to make any determination of Executive’s Disability and consent to such medical professional sharing the results of such examination with a representative of the Board. 

(j) “Date of Termination” means Executive’s “separation from service” (as defined in Section 1.409A-3(a)(1)
of the Treasury Regulations). 
 (k) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(l) “Good Reason” shall constitute any of the following circumstances if they occur without the Executive’s express
written consent during the term of this Agreement: (i) a material diminution in the Executive’s authority, duties or responsibilities such that Executive no longer holds a position with executive level responsibilities consistent with the
Executive’s training and experience; (ii) the Companies require a material change in the Executive’s primary location of employment of more than 100 miles from the location of the Executive’s primary location of employment on
date of this Agreement; (iii) the Companies materially reduce the Executive’s incentive compensation opportunities and employee benefits to a level that is less than is provided to other executives of comparable rank with the Companies;
(iv) a material breach by the Companies of any provision of this Agreement; (v) a material reduction by the Companies in the Executive’s Annual Base Salary (herein defined); (vi) the termination or non-renewal of this Agreement
by the Companies except for the automatic termination of this Agreement at the expiration of the term that includes the date when the Executive reaches 65 years of age. 

  
 3 

 (m) “Severance Benefits” means the payments and other benefits to be provided to
the Executive under Section 3(a) or (b) hereof. 
 2. Term of Agreement. This Agreement shall continue in
effect for an initial period commencing on the Effective Date and ending on August 31, 2013 (the “Initial Term”). Thereafter, this Agreement shall automatically be extended for successive terms of one year (each a “Renewal
Term”), except that this Agreement shall not be renewed and shall terminate automatically and without any action of the Companies or the Executive at the expiration of the term that includes the date when the Executive reaches 65 years of age.
If not sooner terminated, any of the Companies may elect to terminate this Agreement at the expiration of the then current term by delivery of written notice of the termination of this Agreement at least six months prior to the commencement of any
renewal term. 
 3. Severance Benefits. 
 (a) If (A) during the Initial Term of this Agreement the Companies terminate the employment of Executive for any reason other than Cause, death or Disability, or the Executive terminates employment
with the Companies for Good Reason, and (B) the Executive executes the Release as required in Section 3(c) hereof, the Executive shall receive the following benefits: 

(i) Executive shall receive an amount equal to two (2) years of Annual Base Salary; 

(ii) An amount equal to two (2) times the Average Annual Incentive Award(s) and Bonus(es); provided that for any Date of
Termination occurring during the Initial Term, the amount paid under this Section 3(a)(ii) shall not be less than $70,192 Subject to the foregoing, the Average Annual Incentive Award(s) and Bonus(es)” shall be calculated in the manner set
forth in Section 1(b) hereof; and 
 (iii) Payment of the Executive’s monthly COBRA premiums for continued health and
dental insurance coverage for the shorter of the following: eighteen (18) months from the Date of Termination or until the Executive becomes eligible for substantially similar coverage under a subsequent employer’s group health plan; and

 (iv) Outplacement services that are customary to Executive’s position. 

(b) (1) If (A) during a Renewal Term of this Agreement the Companies terminate the employment of Executive for any reason other
than Cause, death or Disability, or the Executive terminates employment with the Companies for Good Reason, and (B) the Executive executes the Release as required in Section 3(c) hereof, the Executive shall receive the following benefits:

 (i) An amount equal to one (1) year of Executive’s Annual Base Salary; 

  
 4 

 (ii) An amount equal to the Average Annual Incentive Award(s) and Bonus(es). The Average
Annual Incentive Award(s) and Bonus(es)” shall be calculated in the manner set forth in Section 1(b) hereof; and 

(iii) Payment of the Executive’s monthly COBRA premiums for continued health and dental insurance coverage for the shorter of the
following: (A) twelve (12) months from the Date of Termination or until the Executive becomes eligible for substantially similar coverage under a subsequent employer’s group health plan; and 

(iv) Outplacement services that are customary to Executive’s position. 

(b) (2) Notwithstanding the provisions of Section 3(b)(1) hereof, the Executive shall receive the Severance Benefits described
in this Section 3(b)(2) in lieu of and not in addition to the Severance Benefits described in Section 3(b)(1) hereof if all of the following conditions are satisfied: (A) a Change of Control Transaction occurs during the term of this
Agreement; (B) during the period commencing on the date of the Change of Control Transaction and ending two (2) years after the effective date of the Change of Control Transaction, (x) the Companies terminate the employment of
Executive for any reason other than Cause, Disability or death, or (y) the Executive terminates employment with the Companies for Good Reason; and (C) the Executive executes the Release as required in Section 3(c) hereof. In
such event, the Severance Benefits payable to the Executive pursuant to this Section 3(b) shall be as follows: 
 (i) An
amount equal to two (2) times the Executive’s Annual Base Salary; 
 (ii) An amount equal to two (2) times the
Average Annual Incentive Award(s) or Bonus(es). The Average Annual incentive Award(s) and Bonus(es) shall be calculated in the manner set forth in Section 1(b) hereof; 
 (iii) Payment of the Executive’s monthly COBRA premiums for continued health and dental insurance coverage for the shorter of the following: eighteen (18) months from the Date of Termination or
until the Executive becomes eligible for substantially similar coverage under a subsequent employer’s group health plan; and 
 (iv) Outplacement services that are customary to Executive’s position. 
 (c)
Executive understands and agrees that the payment of the Severance Benefits described in subparagraphs (i) and (ii) of Section 3(a) or subparagraphs (i) and (ii) of either Section 3(b)(1) or Section 3(b)(2) hereof
is subject to and conditioned upon Executive’s execution of the Release substantially in the form attached hereto as Exhibit A within twenty-two (22) days after the Date of Termination without subsequent revocation by Executive within
seven (7) days after the execution of the Release. Subject to the foregoing, payment of the Severance Benefits, described in subparagraphs (i) (Annual Base Salary) and (ii) (Average Annual Incentive Award(s) or Bonus(es)) of
Section 3(a), Section 3(b)(1) and Section 3(b)(2) hereof shall be made to Executive in cash or good funds in substantially equal installments during the Restricted Period (as defined in Section 6 hereof) in accordance with the
normal payroll practices of ProAssurance in effect as of the Date of Termination commencing on the first payroll payment date following the expiration of thirty (30) days after the Date of

  
 5 

 
Termination; provided that the obligation of the Companies to pay such Severance Benefits to the Executive shall be subject to termination as provided in Section 8 hereof in the event the
Executive violates the covenants under either Section 6 or 7 hereof. The Companies shall withhold from any amounts payable under this Agreement all federal, state, city or other income and employment taxes that shall be required.
Notwithstanding the foregoing, if the Executive is a “specified employee” within the meaning of Code Section 409A(a)(2)(B)(i), the payment schedule for Severance Benefits shall be modified or adjusted to provide that no payments shall
be made until the expiration of six (6) months following the Date of Termination. In the event that payments are so delayed, a lump sum payment of the accumulated unpaid amounts attributable to the six (6) month period shall be made to
Executive on the first day of the seventh month following the Date of Termination. This six month delay shall not apply to any Severance Benefits which are not subject to the requirements of Section 409A of the Code by reason of their being
separation pay upon an involuntary separation from service and their meeting the requirements and limitations of the regulations under the above referenced Code section. In no event shall the aggregate amount of Severance Benefits be reduced as a
result of such modification or adjustment. For purposes of Section 409A of the Code, the right to the series of installment payments is to be treated as a right to receive a series of separate payments. 

(d) The outplacement services included in the Severance Benefits shall be provided to the Executive promptly after the execution of the
Release but not later than the end of the calendar year following the year in which the Date of Termination occurred. 
 (e) The
Executive shall be entitled to the following in addition to and not in limitation of the Severance Benefits: (i) accrued and unpaid base salary as of the Date of Termination; (ii) accrued vacation and sick leave, if any, on Date of
Termination in accordance with the then current policy or plan of the Companies with respect to terminated employees generally; and (iii) vested benefits under the Companies’ employee benefit plans in which the Executive was a participant
on Date of Termination, which vested benefits shall be paid or provided for in accordance with the terms of said employee benefit plans. 
 (f) The Executive shall not be entitled to receive Severance Benefits if employment with the Companies is terminated by reason of death or Disability of Executive; or by reason of termination of
employment by the Executive without Good Reason; or by reason of termination of employment by the Companies with Cause. 
 (g)
The Executive shall be under no duty or obligation to seek or accept other employment and shall not be required to mitigate the amount of the Severance Benefits provided under the Agreement by seeking employment or otherwise; provided, however, that
the Executive shall be required to notify the Companies if the Executive becomes covered by a health or dental care program providing substantially similar coverage, at which time health or dental care continuation coverage provided under this
Agreement shall cease. 
 4. Good Reason for Termination. In the event that Executive desires to terminate employment
with the Companies for Good Reason, the Executive must provide the Companies with written notice no later than 45 calendar days after the Executive knows or should have known that Good Reason has occurred. Following the Executive’s notice, the
Companies shall have 45 calendar days to rectify the circumstances causing the Good Reason. If 

  
 6 

 
the Companies fail to rectify the event(s) causing the Good Reason within the 45 day period after the Executive’s notice, or if any of the Companies delivers to the Executive written notice
stating that the circumstances cannot or shall not be rectified, the Executive shall be entitled to assert Good Reason and terminate employment on or before 90 days after the delivery of the Executive’s notice. Should Executive fail to provide
the required notice in a timely manner, Good Reason shall not be deemed to have occurred as a result of that event. The term of this Agreement shall not be deemed to have expired during the notice period, however, as long as the Executive has
provided notice within the term. 
 5. Cause. If the Executive’s employment relationship with the Companies is
terminated by the Companies for Cause, the Executive shall not be eligible for Severance Benefits and all rights of the Executive and obligations of the Companies under this Agreement shall expire. Any termination of the Executive’s employment
by the Companies for Cause shall be communicated by a notice of termination to the Executive. The notice of termination shall be a written notice indicating the specific termination provision of this Agreement relied upon and shall set forth in
reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under this provision. In the event the Executive disputes the basis for termination for Cause, Executive may elect to bypass
the claims procedure set forth in Section 11 hereof and file for settlement of the dispute in arbitration as provided in Section 12 hereof; provided that if the arbitrator rules in favor of the Executive, the time for the execution of the
Release under Section 3 hereof shall be extended until twenty-two (22) days after the final decision by the arbitrator, and in the event the Executive executes the Release during said twenty-two (22) day period and does not revoke the
Release within seven (7) days after execution, the Executive shall be paid Severance Benefits as provided in Section 3 hereof commencing on the first payroll payment date following the expiration of thirty (30) days after the final
decision of the arbitrator(or if earlier, the December 31 coincident with or immediately following the final decision of the arbitrator); and Executive shall be reimbursed for any COBRA premiums that were paid by Executive in the interim period
(but not exceeding the maximum period specified under Section 3 hereof) between the termination of employment for COBRA purposes and the Date of Termination as determined by the arbitrator, with such reimbursement to be made on the first
payroll payment date following the final decision of the arbitrator (or if earlier, the December 31 coincident with or immediately following the final decision of the arbitrator). 

6. Non-Competition and Nonsolicitation Covenant. The Executive will not during the Restricted Period (herein defined): 

(a) sell, solicit, induce, promote, facilitate, bring about, quote rates for, receive, write, bind, broker, transfer, accept or direct
replacement or renewal insurance coverage or services for, or accept or direct any offer to purchase medical professional liability insurance (as defined below), to or from, a Customer (as defined below). In addition, and without limitation to the
foregoing, Executive shall not otherwise directly or indirectly suggest, advise or attempt to persuade any Customer to discontinue any policy of insurance issued by the Insurance Subsidiary or to cancel, replace or not renew such policies nor shall
Executive direct any Customers to obtain, renew or replace a policy of medical professional liability insurance with or through any person other than Employer; or 

  
 7 

 (b) become Employed by a Competitor Company in a Primary Market Area of an Insurance
Subsidiary, except that Executive may be employed with a Competitor Company so long as and on the condition that the Executive does not participate in the medical professional liability insurance business of the Competitor Company; 

(c) solicit or induce any employees of the Companies to leave such employment or accept employment with any other person or entity, or
solicit or induce any insurance agent of an Insurance Subsidiary to offer, sell or market medical professional liability insurance for a Competitor Company in a Primary Market Area of an Insurance Subsidiary. 

For purposes of this Section 6 only, the following terms shall have the meanings set forth below: 

“Companies” has the meaning set forth in the initial paragraph of this Agreement. 

“Competitor Company” means an insurance company, insurance agency, business, for profit or not for profit organization (other
than the Companies) that provides, or offers to provide medical professional liability insurance to health care providers. 

“Customer” means (A) any health care provider engaged in a podiatric or chiropractic practice who or which was insured by
an Insurance Subsidiary at any time during Executive’s employment with the Companies or (B) any insured or prospective insured of an Insurance Subsidiary with whom Executive had contact with during and in connection with Executive’s
employment with the Companies. 
 “Employed” includes activities as an owner, proprietor, employee, agent, solicitor,
partner, member, manager, principal, shareholder (owning more than 1% of the outstanding stock), consultant, officer, director or independent contractor. 
 “Health care providers” means physicians, dentists, podiatrists, physician assistants, chiropractors, nurse practitioners, other individual health care providers and hospital and other
institutional health care providers. 
 “Insurance Subsidiary” means any direct or indirect subsidiary of ProAssurance
Corporation, including without limitation PICA and PACO Assurance Company, Inc., that offers medical professional liability insurance or non-risk bearing products and services related to underwriting, claims or risk management, or indemnification
for medical professional liability. 
 “Medical professional liability insurance” means medical malpractice insurance
and reinsurance, and equivalent services such as administration of self-insured trusts, claims management services and risk management services for health care providers. “Medical professional liability insurance” does not include services
provided as an employee of a health care provider if such services are rendered solely for the purpose of servicing medical professional liability risk of the employer or that of its employees. 

“Primary Market Area” means any state in which the Insurance Subsidiaries derived more than $10 million in aggregate revenues
from the sale of medical professional liability insurance and non-risk bearing medical professional liability services or products to health care providers in the most recent complete fiscal year prior to the Date of Termination. 

  
 8 

 “Restricted Period” means a period of twelve (12) months from the Date of
Termination; provided that in the event Severance Benefits are due to be paid to the Executive under Section 3(b) (2) hereof, the Restricted Period shall be extended and shall mean a period of twenty-four (24) months from Date of
Termination. 
 7. Confidentiality. Executive will remain obligated under any confidentiality or nondisclosure agreement
with or policy of the Companies (or any of them) that is currently in effect or to which the Executive may in the future be bound. In addition to and without limitation of the foregoing Executive understands, acknowledges and agrees to the
following: 
 (a) During the course of Executive’s employment with the Companies, certain confidential information may have
been divulged to or become known by Executive in the nature of, but not limited to (i) information concerning the Companies’ and their affiliates’ current, former and prospective employees; (ii) business practices and business
plan; (iii) customer information; (iv) contract information; (v) marketing strategies; (vi) business plans; (vii) product information; (viii) policies and procedures; (ix) financial, pricing and wage information;
(x) administrative information; (xi) future plans of the Companies and their affiliates; (xii) and other trade secrets, which is valuable, confidential information of Companies and their affiliates (all of which is referred to herein
as “Confidential Information”), which Confidential Information has been uniquely developed by the Companies and their affiliates and cannot be readily obtained by third parties from outside sources. 

(b) The Confidential Information is important and is an essential asset of the Companies. 

(c) Executive’s knowledge of the Confidential Information could be useful to a competitor of the Companies, and their affiliates
which do or intend to do business in competition with the Companies or their affiliates. 
 In recognition of the facts expressed above,
Executive expressly agrees that Executive shall not use for Executive’s personal benefit, or disclose, communicate or divulge to, or use for the direct or indirect benefit of any person, firm, association or company, any confidential or
competitive material or information of the Companies or their affiliates, or Confidential Information. 
 8 Reasonableness of
Restrictions; Available Remedies. 
 (a) The Companies acknowledge and agree that the duties of Executive may require that
Executive must have and continue to have throughout the period of employment the benefits and use of its goodwill, confidential information and trade secrets to properly carry out Executive’s responsibilities, and that the Companies accordingly
promise to provide Executive with access to new and additional confidential information and trade secrets as they are generated, without regard to the duration of his employment, and to authorize Executive to engage in activities that will create
new and additional confidential information and trade secrets. Executive and the Companies agree that the restrictions contained in Sections 6 and 7 of this Agreement are fair and reasonable in all respects, including the geographic and temporal
restrictions, and that the benefits described in this Agreement, to the extent any separate or special consideration is necessary, are fully sufficient for Executive’s obligations under this Agreement. 

  
 9 

 (b) If the Executive is deemed to have materially breached the non-competition covenants set
forth in Section 6 hereof or the confidentiality covenants set forth in Section 7 hereof, the Companies may, in addition to seeking an injunction or any other remedy they may have, withhold or cancel any remaining payments or benefits due
to the Executive pursuant to Section 3 of this Agreement. The Companies shall give prior or contemporaneous written notice of such withholding or cancellation of payments in accordance with Section 3 hereof. If the Executive violates any
of these covenants, the Companies shall be further entitled to an immediate preliminary and permanent injunctive relief, without bond, in addition to any other remedy which may be available to the Companies. 

9. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Companies and Executive and their
respective devisees, heirs, legal or personal representatives, successors and assigns. Notwithstanding the foregoing, this Agreement is personal to the Executive and the rights and obligations hereunder may not be assigned by Executive without the
prior written consent of ProAssurance. In the event that Executive dies while receiving Severance Benefits under this Agreement, any remaining unpaid Severance Benefits shall be paid to the estate of the Executive following the payment schedule set
forth in Section 3(c) of this Agreement after ProAssurance receives notice of death and payment instructions from the representative of the estate of Executive, but in no event shall any payment be made later than the December 31
immediately following the date payment is due or, if later, the 15th day of the third calendar month following the date payment is due. 
 10. Notice. For purposes of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered by
hand or commercial courier or mailed by certified or registered mail, return receipt requested, postage prepaid, addressed to the respective addresses as set forth below or to such other address as one party may have furnished to the other in
writing in accordance herewith. 
  

					
		 	 Notice to the Executive:
	  	
			
		 	 Ross E. Taubman, DPM
	  	
			
		 	 Notice to the Companies:
	  	
			
		 	 ProAssurance Corporation
	  	Street Address:
		 	 Mailing Address:
	  	100 Brookwood Place
		 	 P. O. Box 590009
	  	Birmingham, Alabama 35209
		 	 Birmingham, Alabama 35259-0009
	  	
		 	 Attention: President: cc Secretary
	  	

  
 10 

 11. Claims Procedure. 

(a) The administrator for purposes of this Agreement shall be ProAssurance (“Administrator”), whose address is 100 Brookwood
Place, Birmingham, Alabama 35209; Telephone: (205) 877-4400. The “Named Fiduciary” as defined in Section 402(a) (2) or ERISA, also shall be ProAssurance. ProAssurance shall have the right to designate one or more employees
of the Companies as the Administrator and the Named Fiduciary at any time, and to change the address and telephone number of the same. ProAssurance shall give the Executive written notice of any change in the Administrator and Named Fiduciary, or in
the address or telephone number of the same. 
 (b) The Administrator shall make all determinations as to the right of any
person to receive benefits under the Agreement. Any denial by the Administrator of a claim for benefits by the Executive (“the claimant”) shall be stated in writing by the Administrator and delivered or mailed to the claimant within ten
(10) days after receipt of the claim, unless special circumstances require an extension of time for processing the claim. If such an extension is required, written notice of the extension shall be furnished to the claimant prior to the
termination of the initial 10-day period. In no event shall such extension exceed a period of ten (10) days from the end of the initial period. Any notice of denial shall set forth the specific reasons for the denial, specific reference to
pertinent provisions of this Agreement upon which the denial is based, a description of any additional material or information necessary for the claimant to perfect the claim, with an explanation of why such material or information is necessary, and
any explanation of claim review procedures, written to the best of the Administrator’s ability in a manner that may be understood without legal or actuarial counsel. 
 (c) A claimant whose claim for benefits has been wholly or partially denied by the Administrator may request, within ten (10) days following the receipt of such denial, in a writing addressed to the
Administrator, a review of such denial. The claimant shall be entitled to submit such issues or comments in writing or otherwise, as the claimant shall consider relevant to a determination of the claim, and the claimant may include a request for a
hearing in person before the Administrator. Prior to submitting the request, the claimant shall be entitled to review such documents as the Administrator shall agree are pertinent to the claim. The claimant may, at all stages of review, be
represented by counsel, legal or otherwise, of the claimant’s choice. All requests for review shall be promptly resolved. The Administrator’s decision with respect to any such review shall be set forth in writing and shall be mailed to the
claimant not later than ten (10) days following receipt by the Administrator of the claimant’s request unless special circumstances, such as the need to hold a hearing, require an extension of time for processing, in which case the
Administrator’s decision shall be so mailed not later than twenty (20) days after receipt of such request. 
 12.
Arbitration. The parties to this Agreement agree that final and binding arbitration shall be the sole recourse to settle any claim or controversy arising out of or relating to a breach or the interpretation of this Agreement, except as either
party may be seeking injunctive relief. Either party may file for arbitration. A claimant seeking relief on a claim for benefits, however, must first follow the procedure in Section 11 hereof and may file for arbitration within sixty
(60) days following claimant’s receipt of the Administrator’s written decision on review under Section 11(c) hereof, or if the Administrator fails to provide any written decision under Section 11

  
 11 

 
hereof, within 60 days of the date on which such written decision was required to be delivered to the claimant as therein provided. The arbitration shall be held at a mutually agreeable location,
and shall be subject to and in accordance with the arbitration rules then in effect of the American Arbitration Association; provided that if the location cannot be agreed upon the arbitration shall be held in Nashville, Tennessee. The arbitrator
may award any and all remedies allowable by the cause of action subject to the arbitration, but the arbitrator’s sole authority shall be to interpret and apply the provisions of this Agreement. In reaching its decision the arbitrator shall have
no authority to change or modify any provision of this Agreement or other written agreement between the parties. The arbitrator shall have the power to compel the attendance of witnesses at the hearing. Any court having jurisdiction may enter a
judgment based upon such arbitration. All decisions of the arbitrator shall be final and binding on the parties without appeal to any court. Upon execution of this Agreement, the Executive shall be deemed to have waived any right to commence
litigation proceedings regarding this Agreement outside of arbitration or injunctive relief without the express consent of ProAssurance. The Companies shall pay all arbitration fees and the arbitrator’s compensation. If the Executive prevails
in the arbitration proceeding, the arbitrator may require the Companies to reimburse the Executive for the reasonable fees and expenses of Executive’s personal counsel for his or her professional services rendered to the Executive in connection
with the enforcement of this Agreement. The amount of expenses eligible for reimbursement during one calendar year may not affect the expenses eligible for reimbursement in any other calendar year. 

13. Miscellaneous. 
 (a) Except insofar as this provision may be contrary to applicable law, no sale, transfer, alienation, assignment, pledge, collateralization or attachment of any benefits under this Agreement shall be
valid or recognized by the Companies. 
 (b) This Agreement is an unfunded deferred compensation arrangement for a member of a
select group of the Companies’ management and any exemptions under ERISA, as applicable to such arrangement, shall be applicable to this Agreement. Nothing in this Agreement shall require or be deemed to require the Companies or any of them to
segregate, earmark or otherwise set aside any funds or other assets to provide for any payments made or required to be made hereunder. 
 (c) It is understood acknowledged and agreed that Executive is and will be an “at will” employee of any one or more of the Companies. Nothing in this Agreement shall be deemed to create an
employment agreement between the Executive and the Companies or any of them providing for Executive’s employment for any fixed duration, nor shall it be deemed to modify or undercut the Executive’s at will employment status with the
Companies. 
 (d) It is understood and agreed by the Companies and Executive that the terms of this Agreement relating to the
payment of Severance Benefits are intended to comply in all respects with the requirements of Code Section 409A. For purposes of determining whether Severance Benefits may be payable to an Executive in compliance with Code Section 409A,
the Executive’s employment will be considered as having been terminated for purposes of this Agreement if the parties reasonably anticipate either (i) that Executive will no longer perform any services for the Companies or (ii) that
the level of bona fide services performed for the 

  
 12 

 
Companies (whether as an employee or independent contractor) will permanently decrease to no more than 20% of the average level of bona fide services performed by Executive over the immediately
preceding 36-month period (or the full period of services to the Companies if Executive has been providing services to the Companies for less than 36 months). 
 (e) Neither the provisions of this Agreement nor the severance benefits provided hereunder shall reduce any amounts otherwise payable, or in any way diminish the Executive’s rights as an employee of
the Companies, whether existing now or hereafter, under any benefit, incentive, retirement, stock option, stock bonus or stock purchase plan, or any employment agreement or other plan or arrangement. 

(f) This Agreement sets forth the entire agreement between the parties with respect to the matters set forth herein and supersedes in
their entirety any prior written or oral agreements or understandings between Executive and the Companies regarding the subject matter of this Agreement; provided, however, that the Companies are bound by the terms of the April 6, 2011 letter
from Gregory P. Jacobson to the Executive during the Initial Term of this Agreement (attached to this Agreement as an Exhibit). This Agreement may not be modified or amended except by written agreement intended as such and signed by all parties.

 (g) The Companies, from time to time, shall provide government agencies with such reports concerning this Agreement as may be
required by law, and shall provide Executive with such disclosure concerning this Agreement as may be required by law or as the Companies may deem appropriate. 
 (h) Executive and the Companies respectively acknowledge that each of them has read and understand this Agreement, that they have each had adequate time to consider this Agreement and discuss it with each
of their attorneys and advisors, that each of them understands the consequences of entering into this Agreement, that each of them is knowingly and voluntarily entering into this Agreement, and that they are each competent to enter into this
Agreement. 
 (i) If any provision of this Agreement is determined to be unenforceable, at the discretion of ProAssurance the
remainder of this Agreement shall not be affected but each remaining provision shall continue to be valid and effective and shall be modified so that it is enforceable to the fullest extent permitted by law. Moreover, in the event this Agreement is
determined to be unenforceable against any of the Companies, it shall continue to be valid and enforceable against the other Companies. 
 (j) This Agreement will be interpreted as a whole according to its fair terms. It will not be construed strictly for or against either party. 

(k) Except to the extent that federal law controls, this Agreement is to be construed according to Delaware law. 

[Signatures on following page] 

  
 13 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date
first written above. 
  

			
	EXECUTIVE:
	
	  

	Ross E. Taubman, DPM
	
	ProAssurance Group Services Corporation
		
	By:	 	  

		 	Victor T. Adamo
	Its:	 	President
	
	ProAssurance Corporation
		
	By:	 	  

		 	Victor T. Adamo
	Its:	 	President
	
	Podiatry Insurance Company of America
		
	By:	 	  

		 	Jerry D. Brant, DPM
	Its:	 	President

  
 14 

 RELEASE IN CONJUNCTION WITH SEVERANCE COMPENSATION 

This Release of Claims (“Release”) is given to ProAssurance Corporation (“ProAssurance”), for itself and for its
subsidiaries (including but not limited to ProAssurance Group Services Corporation and Podiatry Insurance Company of America) and any successor company that has assumed the Agreement to which this Release was an attachment (all such organizations
being referred to in this Release as the “Companies”) and Ross E. Taubman, DPM (“Executive”). 
 The
Companies and Executive have agreed to terminate their employment relationship. To effect an orderly termination, the Executive, and the Companies are entering into this Release. 

1. Effective with the Date of Termination, Executive is relieved of all duties and obligations to the Companies, except as provided in
this Release or any applicable provisions of the Release and Severance Compensation Agreement between Companies and Executive, effective as of September 1, 2011 (“Agreement”), which survive termination of the employment relationship.
Unless otherwise specifically defined herein, capitalized terms shall have the meaning attributed to them in the Agreement. 

2. Executive hereby resigns as an officer and director, as applicable, of the Companies effective on the Date of Termination and hereby
waives any and all rights Executive may otherwise have to continued employment with or re-employment by the Companies or any parent, subsidiary or affiliate of Companies. 
 3. Executive agrees that this Release, the Agreement and the Severance Benefits provided under the Agreement are confidential and shall not be disclosed or published directly or indirectly to third
persons, except as necessary to enforce its terms, by Executive or to Executive’s immediate family upon their agreement not to disclose the fact or terms of this Release, or to Executive’s attorney, financial consultant or accountant,
except that Executive and the Companies may disclose, as necessary, (i) the fact that Executive has terminated Executive’s employment with the Companies, and (ii) the terms of this Agreement and Severance Benefits as required under
the securities laws and regulations and the listing requirements of any stock exchange or national market system and as otherwise required by law. 
 4. Any fringe benefits that Executive has received or currently is receiving from the Companies or its affiliates shall cease effective with the Date of Termination, except as otherwise provided for in
this Release, in the Agreement or by law. 
 5. The parties agree that the terms contained and payments provided for in the
Agreement are compensation for and in full consideration of Employee’s release of claims under this Release, and Executive’s confidentiality, non-compete, non-solicitation and non-disclosure agreements contained in the Agreement.

 6. The Executive shall be under no duty or obligation to seek or accept other employment and shall not be required to
mitigate the amount of the Severance Benefits (as defined and provided under the Agreement) by seeking employment or otherwise, provided, 

  
 15 

 
however, that the Executive shall be required to notify the Companies if the Executive becomes covered by a health or dental care program providing substantially similar coverage, at which time
health or dental care continuation coverage provided under the Agreement shall cease. 
 7. Executive waives, releases, and
forever discharges the Companies and each of their direct or indirect parents, subsidiaries, affiliates, and any partnerships, joint ventures or other entities involving or related to any of the Companies, their parents, subsidiaries or affiliates,
and all present or former employees, officers, agents, directors, successors, assigns and attorneys of any of these corporations, persons or entities (all collectively referred to in this Release as the “Released”) from any and all claims,
charges, suits, causes of action, demands, expenses and compensation whatsoever, known or unknown, direct or indirect, on account of or growing out of Executive’s employment with and termination from the Companies, or relationship or
termination of such relationship with any of the Released, or arising out of related events occurring through the date on which this Release is executed. This includes, but is not limited to, claims for breach of any employment contract; handbook or
manual; any express or implied contract; any tort; continued employment; loss of wages or benefits; attorney fees; employment discrimination arising under any federal, state, or local civil rights or anti-discrimination statute, including
specifically any claims Executive may have under the federal Age Discrimination in Employment Act, as amended, 29 USC §§ 621, et seq.; emotional distress; harassment; defamation; libel; slander; and all other types of claims or
causes of action whatsoever arising under any other state or federal statute or common law of the United States. Notwithstanding anything in this Release to the contrary, nothing in this Release shall be construed to waive, release or discharge the
Companies from making any payments or providing any benefits to Executive in accordance with the terms of the Agreement after the Date of Termination 
 8. The Executive does not waive or release any rights or claims that may arise under the federal Age Discrimination in Employment Act, as amended, after the date on which this Release is executed by the
Executive. 
 9. The Executive acknowledges and agrees that Executive has been advised in writing by this Release, and
otherwise, to CONSULT WITH AN ATTORNEY before Executive executes this Release. 
 10. The Executive agrees that Executive
received a copy of this Release prior to executing the Agreement, that this Release incorporates the Companies’ FINAL OFFER; that Executive has been given a period of at least twenty-two (22) calendar days within which to consider this
Release and its terms and to consult with an attorney should Executive so elect. 
 11. The Executive shall
have seven (7) calendar days following Executive’s execution of this Release to revoke this Release. Any revocation of this Release shall be made in writing by the Executive and shall be received on or before the time of close of business
on the seventh calendar day following the date of the Employee’s execution of this Release at ProAssurance’s address at 100 Brookwood Place, P. O. Box 590009, Birmingham, Alabama 35259-0009, Attention: President: cc Secretary, or such
other place as the Companies may notify Executive in writing. This Release shall not become effective or enforceable until the eighth (8th) calendar day following the Executive’s execution of this Release. 

  
 16 

 12. Executive and the Companies acknowledge that they have read and understand this Release,
that they have had adequate time to consider this Release and discuss it with their attorneys and advisors, that they understand the consequences of entering into this Release, that they are knowingly and voluntarily entering into this Release, and
that they are competent to enter into this Release. 
 13. This Release shall benefit and be binding upon the parties and their
respective directors, officers, employees, agents, heirs, successors, assigns, devisees and legal or personal representatives. 

14. This Release, along with the attached Agreement, sets forth the entire agreement between the parties at the time and date these
documents are executed, and fully supersedes any and all prior agreements or understandings between them pertaining to the subject matter in this Release. This Release may not be modified or amended except by a written agreement intended as such,
and signed by all parties. 
 15. Except to the extent that federal law controls, this Release is to be construed according to
the law of the state of Delaware. 
 16. If any provision of this Release is determined to be unenforceable, at the discretion
of ProAssurance the remainder of this Release shall not be affected but each remaining provision or portion shall continue to be valid and effective and shall be modified so that it is enforceable to the fullest extent permitted by law. 

17. To signify their agreement to the terms of this Release, the parties have executed it on the date set forth opposite their
signatures, or those of their authorized agents, which follow. 
  

					
	 	 	 	  	EXECUTIVE
			
		 		  	  

	Dated:                     	 		  	Ross E. Taubman

  
 17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]